Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Journal of the Neurological Sciences
|
March 12, 2015
L-DOPA-induced dyskinesia, is striatal dopamine depletion a requisite?
Philippe Huot
Neurodegenerative Disease Management
|
May 20, 2022
An overview of the active clinical trials for Parkinson's disease psychosis
Cynthia Kwan, Philippe Huot
Movement Disorders Clinical Practice
|
October 27, 2018
Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease
Emmanuelle Pourcher, Philippe Huot
Current Opinion in Neurobiology
|
January 22, 2026
The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease
Margaux Teil, Philippe Huot
Neurodegenerative Disease Management
|
May 19, 2022
Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
Imane Frouni, Philippe Huot
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 30, 2020
The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results
Francis Beaudry, Philippe Huot
Journal of Neurochemistry
|
February 9, 2007
Dopaminergic neurons intrinsic to the striatum
Philippe Huot, André Parent
BMJ Case Reports
|
October 11, 2014
A generalised sensation of coldness following introduction of rosuvastatin therapy
Niem Tu Huynh, Philippe Huot
Experimental Brain Research
|
July 2, 2013
The serotonergic system in motor and non-motor manifestations of Parkinson's disease
Philippe Huot, Susan H Fox
Brain : a Journal of Neurology
|
December 5, 2006
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea
Philippe Huot, Martin Lévesque, André Parent
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Journal of the Neurological Sciences
|
March 12, 2015
L-DOPA-induced dyskinesia, is striatal dopamine depletion a requisite?
Philippe Huot
Neurodegenerative Disease Management
|
May 20, 2022
An overview of the active clinical trials for Parkinson's disease psychosis
Cynthia Kwan, Philippe Huot
Movement Disorders Clinical Practice
|
October 27, 2018
Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease
Emmanuelle Pourcher, Philippe Huot
Current Opinion in Neurobiology
|
January 22, 2026
The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease
Margaux Teil, Philippe Huot
Neurodegenerative Disease Management
|
May 19, 2022
Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
Imane Frouni, Philippe Huot
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 30, 2020
The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results
Francis Beaudry, Philippe Huot
Journal of Neurochemistry
|
February 9, 2007
Dopaminergic neurons intrinsic to the striatum
Philippe Huot, André Parent
BMJ Case Reports
|
October 11, 2014
A generalised sensation of coldness following introduction of rosuvastatin therapy
Niem Tu Huynh, Philippe Huot
Experimental Brain Research
|
July 2, 2013
The serotonergic system in motor and non-motor manifestations of Parkinson's disease
Philippe Huot, Susan H Fox
Brain : a Journal of Neurology
|
December 5, 2006
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea
Philippe Huot, Martin Lévesque, André Parent
Page
of 11